Skip to main content
✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026
Rates
NAICS 325412ManufacturingFY2027 Fee WaiversLending Growing

How Much Can Pharmaceutical Preparation Manufacturing Businesses Get in SBA Loans?

611 SBA loans totaling $471.9M have been approved for pharmaceutical preparation manufacturing businesses (NAICS 325412). The average approved SBA loan is $772K, which is 127% above avg the $340K national average. 223 active lenders fund this industry with a 9.1% default rate on the matured 2018-2021 loan cohort.

Low default risk9.1% vs 15.4% all industry avg

At 9.1%, Pharmaceutical Preparation Manufacturing sits well below the 15.4% all industry SBA default rate (charged off as a share of resolved loans), low default risk relative to other SBA industries. The capital source prices this risk into rate and structure.

Quick Answer

NAICS 325412 (Pharmaceutical Preparation Manufacturing) received 611 SBA loans worth $471.9M across 5+ states. Average loan $772K, average term 135 months, 9.1% default rate (resolved loan basis).223 active SBA approved lenders fund this industry.Manufacturers in NAICS 31 to 33 qualify for FY2027 SBA fee terms and can access the MARC revolving credit program. There are approximately 1,444 U.S. establishments in this industry (Census 2022).

611
Total SBA Loans
$471.9M
Total Volume
$772K
Avg Loan Size
127% above avg
223
Active Lenders
135 mo
Avg Term
4% above avg
10,304
Jobs Supported

Is SBA Lending Growing for Pharmaceutical Preparation Manufacturing?+107% growth

20
23
21
15
15
25
13
14
17
29
16
17
18
19
20
21
22
23
24
25
$25.6M
$23.9M
$23.0M
$18.7M
$12.5M
$44.9M
$13.4M
$32.8M
$27.4M
$37.4M

FY2027 Manufacturing Fee Waivers Active

The SBA has waived both 504 fees for manufacturers in NAICS 31 to 33 through September 30, 2027:

$0 Fees

504 loans: all guaranty fees waived for manufacturing

$0 Fees

7(a) loans of $700,000 or less: 0% upfront fee for manufacturers

$5M MARC

Revolving credit line: manufacturers only, launched Oct 2025

The proposed Made in America Manufacturing Finance Act (H.R. 3174) would double SBA limits to $10M for domestic manufacturers, currently passed House, awaiting Senate vote.

Which SBA Program Do Pharmaceutical Preparation Manufacturing Businesses Use Most?

SBA 7(a)498 (82%)
SBA 504113 (18%)

What Is the Best SBA Loan for Pharmaceutical Preparation Manufacturing?

SBA 504

Popular for manufacturing equipment and real estate, with 504 fees waived in FY2027

Industry avg loan: $772K
Typical term: 135 months
Historical avg rate: 6.98%
223+ lenders active in this industry
Default rate (2018 to 21 matured cohort): 9.1%

Where Are Pharmaceutical Preparation Manufacturing SBA Loans Most Common?

#1
CA
85 loans
$59.9M
#2
NJ
65 loans
$67.6M
#3
FL
57 loans
$52.2M
#4
NY
45 loans
$38.2M
#5
TX
38 loans
$39.5M

SBA Lending Activity in Pharmaceutical Preparation Manufacturing

223 SBA lenders have funded 611 loans to pharmaceutical preparation manufacturing businesses (NAICS 325412). Which lender approves your deal depends on your location, loan size, credit profile and time in business, not on who funded someone else. PeerSense makes the introduction.

Loans funded
611
Active lenders
223
Total volume
$471.9M
Avg loan size
$772K

Pharmaceutical Preparation Manufacturing Industry Context

U.S. Establishments
1,444
U.S. Census Bureau · 2022
SBA Penetration
42.31%
SBA loans per establishment

Talk to PeerSense

PeerSense sources capital for pharmaceutical preparation manufacturing businesses. The capital source sets the terms. No upfront fee. Talk to PeerSense. Referral fee at closing.

$0

Retainers

10%

Down with SBA 7(a)

25yr

Terms Available

Talk to PeerSense about financing a Pharmaceutical Preparation Manufacturing business.

Tell us your loan amount and use of funds. PeerSense sources capital. The capital source sets the terms.

SBA 7(a) / 504: PeerSense will reach out. No obligation.

How big is your deal?
Where are you in the deal?
Equity or down payment ready
Credit score
Timeline to close
SBA already on the books?
What best describes your company
Liquid funds available outside this deal

Referral fee realized at closing · Or call (317) 452 6990

How Does SBA Lending Work for Pharmaceutical Preparation Manufacturing Businesses?

Across all SBA loan programs, 611 loans have been approved for businesses classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing), representing $471.9M in total capital deployed. The average approved loan of $772K is 127% above avg the national SBA average of $340K, with typical repayment terms of 135 months.

SBA lending for pharmaceutical preparation manufacturing is accelerating. Loan volume has grown approximately 107% over recent fiscal years. This upward trajectory suggests expanding access to capital and growing lender confidence in this sector. Peak activity occurred in FY2025.

The industry sees a balanced mix of SBA programs, with 18% of loans using the 504 program for fixed asset acquisition and the majority using 7(a) for its flexibility across working capital, equipment, and business acquisition uses. SBA 7(a) loans offer up to $5M with terms up to 25 years for real estate.

As a manufacturing business under NAICS 31 to 33, you qualify for FY2027 SBA fee terms through September 30, 2027. For manufacturers, the SBA has waived the 504 upfront guaranty fee and annual service fee, and the 7(a) upfront fee is 0% on loans of $700,000 or less. Additionally, the MARC (Manufacturers' Access to Revolving Credit) program launched in October 2025, offering up to $5M in revolving credit exclusively for domestic manufacturers, a first for SBA lending.

Frequently Asked Questions: Pharmaceutical Preparation Manufacturing SBA Loans

What is the average SBA loan size for pharmaceutical preparation manufacturing businesses?
Based on 611 approved SBA loans, the average loan size for pharmaceutical preparation manufacturing (NAICS 325412) is $772K. This compares to the national SBA average of $340K across all industries.
Which SBA loan program is best for a pharmaceutical preparation manufacturing business?
SBA 504 is the most commonly used SBA program for pharmaceutical preparation manufacturing businesses. Popular for manufacturing equipment and real estate, with 504 fees waived in FY2027. PeerSense can analyze your specific deal to determine the optimal program.
How many lenders fund SBA loans for pharmaceutical preparation manufacturing?
223 different SBA approved lenders have funded loans in this industry. Not all lenders are equally active in every industry. Talk to PeerSense. The capital source sets the terms for a pharmaceutical preparation manufacturing file.
Are there SBA fee waivers for manufacturing businesses in 2026?
Yes. In FY2027, the SBA has waived both 504 fees for manufacturers, including debt refinance with or without expansion. The upfront 7(a) fee is also 0% for manufacturers on loans of $700,000 or less. The MARC program offers revolving credit up to $5M for manufacturers.
How does PeerSense help pharmaceutical preparation manufacturing businesses get SBA loans?
PeerSense is a capital advisory firm. Talk to PeerSense about a pharmaceutical preparation manufacturing file. The capital source sets the terms. No upfront fee. The desk is paid at closing.

Data aggregated from SBA loan records (1992 to 2025). Pharmaceutical Preparation Manufacturing defined by NAICS code 325412. Not financial advice. PeerSense sources capital through a curated network of commercial lenders and capital sources. Consult a lending professional before making financial decisions.